Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Publications for all Oxford Principal Investigators within the CAMS Oxford Institute are included here, please use the search functions for publications related to specific Principal Investigators.

Re-evaluation of human BDCA-2+ DC during acute sterile skin inflammation

Journal article

Chen Y-L. et al, (2020), The Journal of Experimental Medicine, 217

Natural killer cells get under your skin.

Journal article

Ogg G., (2020), Science translational medicine, 12

Association of dengue virus-specific polyfunctional T-cell responses with clinical disease severity in acute dengue infection.

Journal article

Wijeratne DT. et al, (2019), Immunity, inflammation and disease, 7, 276 - 285

Resistance to apoptosis underpins the corticosteroid insensitivity of group 2 innate lymphoid cells.

Journal article

Luo J. et al, (2019), The Journal of allergy and clinical immunology, 144, 1722 - 1726.e10

Proof-of-concept clinical trial of etokimab shows a key role for IL-33 in atopic dermatitis pathogenesis

Journal article

Chen Y-L. et al, (2019), Science Translational Medicine, 11, eaax2945 - eaax2945

Atopic dermatitis epidemiology and unmet need in the United Kingdom.

Journal article

Cork MJ. et al, (2019), The Journal of dermatological treatment, 1 - 9

Altered monocyte response to the dengue virus in those with varying severity of past dengue infection.

Journal article

Kamaladasa A. et al, (2019), Antiviral research, 169

Capturing the antigen landscape: HLA-E, CD1 and MR1.

Journal article

Ogg G. et al, (2019), Current opinion in immunology, 59, 121 - 129

Fevipiprant, a selective prostaglandin D2 receptor 2 antagonist, inhibits human group 2 innate lymphoid cell aggregation and function.

Journal article

Hardman C. et al, (2019), The Journal of allergy and clinical immunology, 143, 2329 - 2333

FEVIPIPRANT INHIBITS PROSTAGLANDIN D2 MEDIATED ACTIVATION OF GROUP 2 INNATE LYMPHOID CELLS (ILC2S)

Conference paper

Sandham D. et al, (2019), RESPIROLOGY, 24, 105 - 105

A preliminary study on efficacy of rupatadine for the treatment of acute dengue infection

Journal article

Malavige GN. et al, (2018), Scientific Reports, 8

Activated innate lymphoid cell populations accumulate in human tumour tissues

Journal article

Salimi M. et al, (2018), BMC Cancer, 18

Role of NS1 antibodies in the pathogenesis of acute secondary dengue infection

Journal article

Jayathilaka D. et al, (2018), Nature Communications, 9

Quantification of dengue virus specific T cell responses and correlation with viral load and clinical disease severity in acute dengue infection

Journal article

Wijeratne DT. et al, (2018), PLOS Neglected Tropical Diseases, 12, e0006540 - e0006540

Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s)

Conference paper

Chen W. et al, (2018), EUROPEAN RESPIRATORY JOURNAL, 52

Type-2 CD8+T lymphocytes responsive to PGD2/LTE4 in severe eosinophilic asthma

Conference paper

Hinks T. et al, (2018), EUROPEAN RESPIRATORY JOURNAL, 52

Load More